Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/03/012516
CTRI/2018/03/012516
Not yet recruiting
Phase 2

An open label, prospective, phase II,clinical study to evaluate efficacy and safety of syp.JTV in the bronchitis

Aushadhi Bhavan0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- BronchitiscoughDysnoeasore throatNasal congestion

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Aushadhi Bhavan
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •subjects with productive cough associated with acute bronchitis, dysnoea, wheezing, chest pain, sore throat, nasal congestion

Exclusion Criteria

  • •Subjects with Diabetes Mellitus Type I and uncontrolled Diabetes Mellitus Type II, Subjects with uncontrolled Hypothyroidism or Hyperthyroidism, Known cases of Severe/Chronic Hepatic or Renal disease, any active malignancy. Subjects giving history of significant cardiovascular event \< 12 weeks prior to randomization. Subjects ECG demonstrating any signs of uncontrolled arrhythmia / acute ischemia.
  • •Subjects X\- ray chest showing any active lesion of tuberculosis and pnumonia. Subjects having severe bronchiectasis, Smokers cough, Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.

Investigators

Sponsor
Aushadhi Bhavan

Similar Trials

Not yet recruiting
Phase 2
Efficacy and Safety of Barphani Ointment in patients suffering from Chronic plaque PsoriasisHealth Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
CTRI/2019/08/020504Ayurved Sanshodhan Vibhag
Not yet recruiting
Phase 2
Effectivity of Barphani Ointment in patients suffering from Eczema.Health Condition 1: - Health Condition 2: L239- Allergic contact dermatitis, unspecified cause
CTRI/2019/08/020618Ayurved Sanshodhan Vibhag
Not yet recruiting
Phase 2
The study of testing effect of syp.Rubyclin in discoloration and itching of skiHealth Condition 1: null- Eczema skin disorders redness itching burning
CTRI/2018/03/012718Aushadhi Bhavan
Completed
Phase 2
To evaluate the safety and efficacy of Arnophyte Cream in subjects with HerpesHealth Condition 1: null- Early signs & symptoms of recurrent HSV-2Health Condition 2: B008- Other forms of herpesviral infections
CTRI/2018/01/011171Piramal Enterprises Limited40
Completed
Phase 2
To assess the safety and effectiveness of DPOR/JR2007 Tablets in Osteoarthritis of the Knee.
CTRI/2017/07/009054Deltas Pharma45